We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

11 hedge funds and large institutions have $1.78M invested in Achieve Life Sciences in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0.17% more ownership

Funds ownership: 0.93% → 1.09% (+0.17%)

5% less capital invested

Capital invested by funds: $1.86M → $1.78M (-$87.2K)

52% less funds holding

Funds holding: 23 → 11 (-12)

92% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 12

Holders
11
Holders Change
-12
Holders Change %
-52.17%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
2
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$845K
2
SCM
Sio Capital Management
New York
+$814K
3
Renaissance Technologies
Renaissance Technologies
New York
+$160K
4
WVP
Worth Venture Partners
New Jersey
+$109K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$189

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$93K
2
Citadel Advisors
Citadel Advisors
Florida
-$84K
3
VF
Virtu Financial
New York
-$82K
4
Walleye Trading
Walleye Trading
New York
-$68K
5
ARTA
A.R.T. Advisors
New York
-$46K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sio Capital Management
New York
$723K +$814K +21,570 +260%
AC
2
Armistice Capital
New York
$542K +$845K +22,400 New
Renaissance Technologies
3
Renaissance Technologies
New York
$305K +$160K +4,240 +51%
WVP
4
Worth Venture Partners
New Jersey
$108K +$109K +2,882 +180%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$45K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$43K +$189 +5 +0.3%
BlackRock
7
BlackRock
New York
$10K – – –
UBS Group
8
UBS Group
Switzerland
$1K -$11.3K -300 -86%
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Quebec, Canada
$98 – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
– -$93K -1,482 Closed
Citadel Advisors
11
Citadel Advisors
Florida
– -$84K -1,329 Closed
VF
12
Virtu Financial
New York
– -$82K -1,309 Closed
Walleye Trading
13
Walleye Trading
New York
– -$68K -1,086 Closed
ARTA
14
A.R.T. Advisors
New York
– -$46K -730 Closed
PAM
15
Panagora Asset Management
Massachusetts
– -$13K -208 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$1.89K -50 -98%
BA
17
Ballew Advisors
Mississippi
– -$1K -30 Closed
ASN
18
Advisory Services Network
Georgia
– -$2K -25 Closed
TRCT
19
Tower Research Capital (TRC)
New York
– -$2K -25 Closed

ACHV Hedge Fund Activity: Q4 2018 in Review

11 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2018, worth a combined $1.78M — down 4.7% from $1.86M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ACHV and 1 opened new positions — a net loss of 11 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $845K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $93K sold.

  • 11 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2018, down from 23 in Q3 2018.
  • Funds reported $1.78M of Achieve Life Sciences stock for Q4 2018, down 4.7% quarter-over-quarter.
  • 1 fund opened new Achieve Life Sciences positions in Q4 2018 and 12 closed out, a net change of -11 holders.
  • The largest Achieve Life Sciences buyer in Q4 2018 was Armistice Capital, an estimated $845K added.
  • The largest Achieve Life Sciences seller in Q4 2018 was Susquehanna International Group, an estimated $93K sold.

Based on aggregated 13F filings for Q4 2018.